Medical beauty

Exosomes, PDRN, needling, cold plasma, light and next-generation acids.

Medical beauty

PHAs and succinic acid: the peel that leaves the lipids in place

Gluconolactone and lactobionic acid move more slowly than glycolic. On visible vessels and a thin barrier, that slower kinetic is the professional starting point.

Julian Vance · 2026-10-12

Read

Medical beauty

Red and near infrared after a peel: dose, distance, cytochrome c oxidase

Photobiomodulation around 630 and 850 nanometres meets complex IV. Fluence, goggles and the photosensitiser question belong in the aftercare sheet, not in a reel.

Marc Oberst · 2026-10-11

Read

Medical beauty

Cold plasma in the cabin: bioburden, ozone, and the poster you do not adopt

Cold atmospheric plasma lowers surface bioburden and can settle a wound edge. Rosacea, acne and inflammation as a disease stay outside the advertising.

Marc Oberst · 2026-10-10

Read

Medical beauty

Microneedling, properly: stamp, pen, RF, and the hygiene that decides the scar

Mechanical channels and radiofrequency heat are different injuries. Depth, joules, scar shape and a sterile unit dose separate a result from an infection.

Dr. Claire Moreau · 2026-10-09

Read

Medical beauty

PDRN: salmonid DNA fragments, the A2A path, and the consent that has to precede the glow

Polydeoxyribonucleotides act through adenosine A2A and can raise VEGF in models. Species, purification and fish-protein allergy belong in the talk before the ampoule opens.

Dr. Claire Moreau · 2026-10-08

Read

Medical beauty

Exosomes after needling: size, source, and the vial that has to be sterile

Vesicles of 30 to 150 nanometres are a fraction, not a growth-factor myth. Source, markers, particle count and sterility decide whether the cabin may use them.

Dr. Claire Moreau · 2026-10-07

Read